Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Maximizing Investigators' Research Award (MIRA) (R35 - Clinical Trial Optional)
Due May 26, 2028National Institutes of Health · Amount varies
Open to eligible NIGMS-funded investigators and new investigators at U.S. institutions; foreign organizations are not eligible, and projects with foreign subawards are excluded. This NIH R35 (MIRA) gives an investigator stable, flexible single-grant support for their lab's research within the NIGMS mission, rather than project-by-project funding. Early-stage investigators should use the separate ESI MIRA notice.
ResearchersSchools & universitiesNonprofitsGovernment / tribalMind and Body Interventions to Restore Whole Person Health via Emotional Well-Being Mechanisms (R61/R33 Clinical Trial Required)
Due Jun 7, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R61/R33 funds mechanistic clinical research on how mind-and-body interventions (e.g., meditation, yoga, acupuncture) affect emotional well-being and whole-person health, in two milestone-tied phases. Strong preliminary data are expected.
ResearchersSchools & universitiesNonprofitsGovernment / tribalINCLUDE Project: Transformative Research Awards for Down syndrome (R01 Clinical Trial Not Allowed)
Due Jun 15, 2028National Institutes of Health · Up to $500K
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R01 funds groundbreaking, high-impact Down syndrome research across any relevant topic, with no preliminary data required. Awards up to about $500,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreINCLUDE Project: Exploratory/Developmental Research Awards for Down syndrome (R21 Clinical Trial Not Allowed)
Due Jun 15, 2028National Institutes of Health · Up to $200K
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R21 funds exploratory, higher-risk Down syndrome research — feasibility studies, novel methods, or new applications of existing techniques. Awards up to about $200,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribalINCLUDE Project: Clinical Trials Phased Awards for Down syndrome Research (R61/R33 Clinical Trial Required)
Due Jun 15, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH R61/R33 funds milestone-driven development of clinical trials to treat co-occurring health conditions in people with Down syndrome — up to two years of planning followed by up to three years of trial support. Clinical trials are required.
ResearchersSchools & universitiesNonprofitsGovernment / tribalNative American Research Centers for Health (NARCH) Planning Grants (R34 - Clinical Trial Not Allowed)
Due Jul 7, 2028National Institutes of Health · Amount varies
Open specifically to federally recognized American Indian/Alaska Native tribes, tribal colleges and universities, tribal health programs, and tribal organizations. This NIH R34 planning grant funds preparatory work to develop competitive Native American Research Centers for Health (NARCH) applications. Eligibility is narrow — limited to AI/AN tribal entities; award size follows standard R34 limits.
Government / tribalSchools & universitiesResearchersNarrow eligibilityClinical Trial Readiness for Rare Diseases, Disorders, and Syndromes (R21 Clinical Trial Not Allowed)
Due Jul 20, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R21 funds projects that improve clinical-trial readiness for rare diseases — developing biomarkers and outcome measures, or characterizing a disease's course to enable future trials. Award size follows standard R21 limits.
ResearchersSchools & universitiesNonprofitsGovernment / tribalDevelopment of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
Due Aug 21, 2028National Institutes of Health · Up to $3M
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH UG3/UH3 funds discovery and development of interventions — medications and devices — to prevent and treat substance use disorders and overdose, including preclinical and clinical studies. Awards up to about $3,000,000.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreTransformative Non-Invasive/Minimally Invasive Technologies for Imaging the Olfactory System Across Scales (R01 CT Optional)
Due Aug 21, 2028National Institutes of Health · Up to $500K
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 funds development of non-invasive or minimally invasive technologies to image the human olfactory system at high resolution. Awards up to about $500,000; multidisciplinary teams are encouraged.
ResearchersSchools & universitiesNonprofitsGovernment / tribal+1 moreStephen I. Katz Early Stage Investigator Research Project Grant (R01 Clinical Trial Not Allowed)
Due Aug 25, 2028National Institutes of Health · Amount varies
Open to U.S. universities, research institutions, nonprofits, and certain government/tribal organizations; foreign organizations are not eligible. This NIH R01 supports early-stage investigators pursuing a new research direction, and applications must include no preliminary data. Award size follows standard R01 limits; aimed at researchers early in their independent careers.
ResearchersSchools & universitiesNonprofitsGovernment / tribalSupport for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $100K
This NIH award (SuRE, up to $100,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited higher education institutions who do not currently hold other NIH research project grants, aiming to build research capacity and student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is under $100,000, and the application deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilitySupport for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
Due Sep 7, 2028National Institutes of Health · Up to $125K
This NIH award (SuRE-First, up to $125,000) funds investigator-initiated biomedical research by full-time faculty at resource-limited institutions who have never previously held an independent, peer-reviewed external research grant, aiming to build research capacity and provide student research experience. Foreign organizations and their non-U.S. components are not eligible. The maximum award is small, and the deadline is not imminent.
Schools & universitiesResearchersSmall awardNarrow eligibilityExploratory Grants in Cancer Control (R21 Clinical Trial Optional)
Due Sep 7, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH/NCI R21 funds early-stage, exploratory research on cancer control — prevention behaviors, screening, etiology, and novel methods. Award size follows standard R21 limits.
ResearchersSchools & universitiesNonprofitsGovernment / tribalMethod to Extend Research in Time (MERIT) Award Extension Request (Type 4 eSubmission Clinical Trial Optional)
Due Sep 7, 2028National Institutes of Health · Amount varies
For existing NCI early-stage-investigator MERIT (R37) awardees applying to extend their award, submitted through their U.S. or eligible institution. The extension provides up to seven years of total support across two segments, giving early-career cancer researchers extra time before a renewal. Eligibility is narrow — limited to current ESI MERIT grantees.
ResearchersSchools & universitiesNarrow eligibilityLimited Competition: Superfund Hazardous Substance Research and Training Program (P42 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Up to $1.8M
This NIH/NIEHS P42 grant funds Superfund Research Program Centers that combine biomedical and environmental science and engineering to study hazardous substances. By law, eligibility is limited to accredited institutions of higher education, though they may subcontract with other organizations and governments. Awards are large (up to roughly $1.75M), and foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersLarge awardNarrow eligibilityAvant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Amount varies
Open to U.S. and foreign research institutions, universities, nonprofits, and certain government/tribal organizations. This NIH DP1 (Avant-Garde/Avenir) funds high-risk, high-reward research on HIV and substance use — basic, clinical, translational, or implementation science. It backs bold, transformative ideas; award size follows the DP1 mechanism.
ResearchersSchools & universitiesNonprofitsGovernment / tribalCancer Center Support Grants (CCSGs) for NCI-designated Cancer Centers (P30 Clinical Trial Optional)
Due Sep 25, 2028National Institutes of Health · Amount varies
This NIH/NCI P30 Cancer Center Support Grant funds NCI-designated Cancer Centers to integrate their cancer research into a coordinated enterprise. Eligibility is highly restrictive: applicant institutions must already have a large cancer-focused NIH funding base (for example, $6M or $10M in annual direct costs depending on center type). Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.
Schools & universitiesResearchersNarrow eligibilityAnimal and Biological Material Resource Centers (P40 Clinical Trial Not Allowed)
Due Sep 26, 2028National Institutes of Health · Amount varies
This NIH/ORIP P40 grant funds Animal and Biological Material Resource Centers that maintain specialized animal colonies, cell and tissue cultures, genetic stocks, and related services for the biomedical research community. Proposed centers must have broad relevance across multiple NIH Institutes. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and foreign components are not allowed.
ResearchersSchools & universitiesNarrow eligibilityResource-Related Research Projects for Development of Models and Related Materials for Studying Human Health and Diseases (R24 Clinical Trials Not Allowed)
Due Sep 28, 2028National Institutes of Health · Amount varies
This NIH/ORIP R24 grant funds research organizations to develop, characterize, or improve models of human health and disease (including new approach methodologies) that are broadly useful across two or more NIH Institutes. Projects narrowly tied to a single disease or to one Institute's interests will not be accepted. Foreign organizations, foreign components of U.S. organizations, and foreign components are not eligible or allowed.
ResearchersSchools & universitiesNarrow eligibilityBRAIN Initiative: Research Resource Grants for Technology Integration and Dissemination (U24 Clinical Trial Not Allowed)
Due Oct 6, 2028National Institutes of Health · Amount varies
This NIH BRAIN Initiative U24 grant funds organizations to disseminate and integrate existing neuroscience research resources (tools, reagents, training, and access to platforms) into the broader research community. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, and applications involving funded foreign subawards/subcontracts will be rejected. Applicants are typically established research institutions with an existing resource to share.
ResearchersSchools & universitiesNarrow eligibility